Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)

Arthritis & Rheumatism

Volumn 31, Issue 4, 1988, Pages 525-532

  Reimer, Georg ^a,b,c   Steen, Virginia D ^a,c   Penning, Carol A ^a,c   Medsger, Thomas A ^a,c   Tan, Eng M ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ARTHROPATHY; CELL NUCLEOLUS ANTIGEN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCLERODERMA;

ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; NUCLEAR PROTEINS; PRECIPITATION; RIBONUCLEOPROTEINS; RNA POLYMERASE I; SCLERODERMA, SYSTEMIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023904706     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780310409     Document Type: Article

References (39)

1. Diversity of antinuclear antibodies in progressive systemic sclerosis: anti‐centromere antibody and its relationship to CREST syndrome
2. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis
3. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease
4. Identification of a nuclear protein (Scl‐70) as a unique target of human antinuclear antibodies in scleroderma
5. High liters of autoantibodies to topoisomerase I (Scl‐70) in sera from scleroderma patients
6. Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase
7. Scl‐70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as topoisomerase I
8. Autoantibody to centromere (kinetochore) in scleroderma sera
9. Kinetochore structure, duplication and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients
10. Human anticentromere antibodies: distribution, characterization of antigens and effect on microtubules organization
11. Human anticentromere sera recognize a 19.5 kD nonhistone chromosomal protein from HeLa cells
12. Three human chromosomal autoantigens are recognized by sera from patients with anti‐centromere antibodies
13. Antinucleolar antibodies: their frequency and diagnostic association
14. Antinucleolar antibodies in human sera
15. Detection of a nucleolar 7‐2 ribonucleoprotein and cytoplasmic 8‐2 ribonucleoprotein with autoantibodies from patients with scleroderma
16. Sequential association of nucleolar 7‐2 RNA with two different autoantigens
17. G‐dimethylarginine
18. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera
19. r 34,000 nucleolar protein of the U3 RNP particle
20. Autoantibody to RNA polymerase I in scleroderma sera
21. Immunolocalization and partial characterization of a nucleolar autoantigen (PM‐Scl) associated with polymyositis/scleroderma overlap syndromes
22. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes
23. Clinical comparison of two variants of progressive systemic sclerosis: diffuse scleroderma and CREST syndrome (abstract)
24. D‐penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis
25. Pulmonary function in progressive systemic sclerosis: comparison of the CREST syndrome variant with diffuse scleroderma
26. Epidemiology of systemic sclerosis (scleroderma)
27. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma
28. Anti‐native DNA antibodies from autoimmune sera also bind to DNA in mitochondria
29. Cleavage of structural proteins during assembly of the head of bacteriophage T4
30. Rapid isolation of nucleoli from detergent purified nuclei of various tumor and tissue culture cells
31. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application
32. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine
33. The CREST syndrome: a distinct serologic entity with anticentromere antibodies
34. Anticentromere antibody: clinical correlations and association with favorable prognosis in patients with scleroderma variants
35. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis
36. Scl‐86, a marker antigen for diffuse scleroderma
37. Zentromerantikorper und Antikorper gegen Scl‐70 Nucleoprotein bei progressiver Sklerodermie
38. Scl‐70 antibody: a specific marker of systemic sclerosis